Philippe Wolgen
Chief Executive Officer bij CLINUVEL PHARMACEUTICALS LIMITED
Vermogen: 32 M $ op 31-03-2024
Profiel
Philippe Jacques Wolgen is currently the Chief Executive Officer, MD & Director at Clinuvel Pharmaceuticals Ltd.
and also serves as a Director at Clinuvel (UK) Ltd.
He holds an MBA from The Trustees of Columbia University in The City of New York and London Business School, and a doctorate from the University of Utrecht.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 24-11-2023 | 3 425 222 ( 6.83% ) | 32 M $ | 31-03-2024 |
Actieve functies van Philippe Wolgen
| Bedrijven | Functie | Begin |
|---|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Chief Executive Officer | 01-11-2005 |
Clinuvel (UK) Ltd.
 Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Director/Board Member | 25-11-2005 |
Opleiding van Philippe Wolgen
| The Trustees of Columbia University in The City of New York | Masters Business Admin |
| University of Utrecht | Doctorate Degree |
| London Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| CLINUVEL PHARMACEUTICALS LIMITED | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Clinuvel (UK) Ltd.
Clinuvel (UK) Ltd. BiotechnologyHealth Technology Part of Clinuvel Pharmaceuticals Ltd., Clinuvel (UK) Ltd. is a British company founded in 2005 that provides research and development in the field of biotechnology. The private company is based in London, UK. | Health Technology |
